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Abstract
TMF1-regulated nuclear protein 1 (Trnp1) has been shown to exert
potent roles in neural development affecting neural stem cell self-
renewal and brain folding, but its molecular function in the nucleus
is still unknown. Here, we show that Trnp1 is a low complexity
protein with the capacity to phase separate. Trnp1 interacts with
factors located in several nuclear membrane-less organelles, the
nucleolus, nuclear speckles, and condensed chromatin. Importantly,
Trnp1 co-regulates the architecture and function of these nuclear
compartments in vitro and in the developing brain in vivo. Deletion
of a highly conserved region in the N-terminal intrinsic disordered
region abolishes the capacity of Trnp1 to regulate nucleoli and hete-
rochromatin size, proliferation, and M-phase length; decreases the
capacity to phase separate; and abrogates most of Trnp1 protein
interactions. Thus, we identified Trnp1 as a novel regulator of several
nuclear membrane-less compartments, a function important to
maintain cells in a self-renewing proliferative state.
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Introduction
Trnp1 was first identified in breast cancer cells, as a target of TMF1,
an E3 ubiquitin ligase, promoting proliferation (Volpe et al, 2006)
and in a screen for factors regulating neural stem cell (NSC) self-
renewal (Pinto et al, 2008). Trnp1 is highest expressed in subsets of
NSCs that self-renew (Stahl et al, 2013) and its overexpression (OE)
maintain NSCs in a self-renewal state (Stahl et al, 2013; Martinez-
Martinez et al, 2016). Conversely, Trnp1 knock-down (KD)
promotes the differentiation of NSC toward other progenitors,
thereby generating folds in the normally smooth mouse brain (Stahl
et al, 2013). Besides its highly specific expression in neurogenic
sites in the nervous system (Stahl et al, 2013), Trnp1 is also
expressed in many other stem and progenitor cells during develop-
ment (Metzger, 2011), suggesting a common role in promoting
proliferation across tissues. However, how Trnp1 acts at the molec-
ular level in the nucleus is entirely unknown.
The nucleus contains several membrane-less organelles (MLOs)
that are generated and regulated through a process of liquid–liquid-
phase separation, LLPS (Shin & Brangwynne, 2017). Proteins
promoting LLPS share common motifs, including long stretches of
intrinsically disordered regions (IDRs) with low amino acid
sequence complexity (Uversky, 2018). They can initiate low-affinity
transient interaction with several proteins and form homo-oligomers
at the same time, acting as multivalent proteins capable to bind
transiently to hundreds of proteins (Li et al, 2012). These local
protein concentrations have four main functions (Sawyer et al,
2019). First, MLOs may concentrate and, secondly, exclude compo-
nents to facilitate and regulate biochemical reactions within the cell.
Thirdly, MLOs can sequester key effector molecules away from their
site of action. And finally, MLOs may act as reservoirs that permit
rapid recycling of molecules to their nearby sites of activity.
Many nuclear MLOs are disassembled during M-phase (Rai et al,
2018). However, once reassembled, MLOs can remain stable for
long periods of time, even while their components are in a constant
state of dynamic flux with the surrounding nucleoplasm (Phair &
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Misteli, 2000). Examples of nuclear MLOs include nucleoli, which
are sites of rRNA biogenesis (Feric et al, 2016), Cajal bodies, which
serve as an assembly site for small nuclear ribonucleoproteins
(RNPs) (Strzelecka et al, 2010), nuclear speckles, which are storage
compartments for mRNA splicing factors (Spector & Lamond, 2011),
heterochromatin (Larson et al, 2017; Larson & Narlikar, 2018; Liu
et al, 2020), superenhancers (Hnisz et al, 2017; Sabari et al, 2018),
transcription complexes (Boija et al, 2018; Guo et al, 2019; Shrini-
vas et al, 2019), and DNA repair compartments (Kilic et al, 2019;
Pessina et al, 2019). Thus, the nucleus contains several MLOs with
crucial functions for the cell. However, so far, most key players for
MLO biogenesis and architecture act in one specific compartment
and still little is known about how different MLOs are coordinated
(Berchtold et al, 2018; Rai et al, 2018). Here, we show that Trnp1 is
a novel low complexity (LC) protein with the capacity to phase
separate and co-regulate several nuclear MLOs.
Results
Trnp1 is a novel short-lived low complexity protein with the
capacity to phase separate
In order to gain insights into the molecular role of Trnp1, we investi-
gated its biochemical properties. Analysis of the primary structure of
Trnp1 shows that the most conserved parts (100% homology among
all orthologs) are a stretch of 16 amino acids (aa) at its N-terminus
and a long alpha helix region (aa87–144) in the central part (Fig 1A)
with high probability (80%) to form coiled coils (CC) (Fig 1B). Soft-
ware tools for disorder prediction IUPred (Dosztanyi et al, 2005a)
and DisoPred (Dosztanyi et al, 2005b) show two regions of low struc-
tural complexity: one at the N-terminus (aa1–103) and the other at
the C-terminus (aa165–178 and aa196–223) with 82, and 81% of
disorder-promoting aa, respectively (Fig 1A), including Trnp1 in the
category of LC proteins. Consistent with the behavior of LC proteins,
Trnp1-immunostaining shows a punctate pattern, suggestive of
condensates in the nucleoplasm (Figs 1C and 5A).
As many IDR proteins self-interact, we co-expressed Trnp1 fused
to GFP (Trnp1-GFP, referred to as Trnp1-fusion) and untagged
Trnp1 protein in P19 cells that lack endogenous Trnp1 (Fig 1C) and
performed co-immunoprecipitation (IP) using a-GFP antibodies
followed by Western blot (WB) using a-Trnp1 antibodies. This
showed the Trnp1-fusion protein interacting with Trnp1 (Fig 1D)
indicating that Trnp1 is able to self-interact. As most LC proteins
with the capacity to self-interact also phase separate (Alberti et al,
2019), we produced the recombinant Trnp1 protein and used phase-
contrast microscopy to examine the formation of phase-separated
protein-rich condensates, here referred to as droplets. As Trnp1 is a
highly insoluble protein, all the recombinant proteins used in this
work were fused to Maltose Binding Protein (MBP) to solubilize
them and MBP was cleaved before examining their capacity to form
droplets. Notably, Trnp1 recombinant protein, but not the recombi-
nant YFP protein used here as negative control, self-assembles to
form droplets in a dose-dependent manner (from 25 to 6.25 lM)
under physiological conditions (Fig 1E). Notably, addition of
dextran (used here as a crowding agent) caused formation of fibril-
lary solid aggregates, while RNA addition had very little effects on
Trnp1 LLPS and aggregation (Fig 1E). These results indicate that
Trnp1 drives phase separation and hence may play a role in the
formation of MLOs.
As MLOs are dynamic structures during the cell cycle, regulated
by several processes like dilution effects upon nuclear envelope
breakdown in mitosis (Rai et al, 2018) or proteolysis (Wang &
Zhang, 2019), we analyzed Trnp1 protein stability in P19 cells.
When cells were treated with cycloheximide (CHX) to block transla-
tion, transfected Trnp1 was degraded within 4 h and hence has a
short half-life of less than 2 h (Fig EV1A). This degradation was
blocked in the presence of the proteasome inhibitor MG132
(Fig EV1A), indicating that Trnp1 is efficiently and fast degraded via
proteasome.
Structure–function analysis of Trnp1
To understand which parts of the Trnp1 protein were important for
its function and self-interaction capacity, we generated deletion
constructs (Fig 2A), removing the first conserved 16 aa (D1–16) at
the N-terminus, extending this deletion to aa 56 to eliminate the
proline-rich region (D1–56), to aa 97 to delete the entire N-terminal
IDR (D1–97), or to aa 140 to also remove the predicted alpha helix
region (D1–140). Likewise, we also deleted the C-terminal IDR
including the predicted alpha helix region (D95–223) or retaining
the alpha helix and only deleting the C-terminal IDR (D140–223). As
the central alpha helix exhibits a high probability to form CC
(Fig 1B), its aa sequence was mutated such as to interfere with the
formation of the CC but not of the alpha helix structure (mutCC)
(Figs 2A and EV1B). Successful mutation of the CC domain was
confirmed using recombinant peptides containing only the alpha
helix region (aa 95–161), WT or mutated, and size-exclusion chro-
matography coupled to an inline static light scattering (SLS)
analyzer (Fig EV1C).
We then tested the localization of the different Trnp1 deletions
by expressing them together with GFP in cells from embryonic
day (E) 14 cerebral cortex (Fig 2B), comprising stem and progeni-
tor cells as well as young neurons, and in P19 cells (Fig EV1D).
Notably, all Trnp1 proteins lacking the C-terminal part were
detected also in the cytoplasm of both cell types (Figs 2B and
EV1D), indicating that this part is responsible for the restricted
nuclear localization. While no NLS consensus sequence could be
predicted in Trnp1, its C terminus is rich in arginines (Fig 1A),
known to be important for nuclear import (Palmeri & Malim,
1999). Conversely, all N-terminal truncated proteins were mostly
detected in the nucleus (Figs 2B and EV1D). For accurate quan-
tification of the localization of these deletion constructs, nuclear
and cytoplasmic fractionations were performed with P19 cells
transfected with these mutant constructs (Fig 2C). While most of
the WT Trnp1 and the N terminal truncated proteins are nuclear,
the C-terminal deletion constructs are mostly contained in the
cytoplasmic fraction (Fig 2C), confirming the crucial role of
the C-terminus in nuclear retention of Trnp1. In contrast, the
mutCCTrnp1 protein is located in both fractions when expressed
in P19 cells (Fig 2C). Notably, its nuclear retention is larger in
cells with endogenous Trnp1 (Fig EV1E) and its knockdown (KD)
using a previously verified shRNA against the 30 UTR of endoge-
nous Trnp1 (Stahl et al, 2013) reduces the remnant nuclear local-
ization of the mutCCTrnp1 lacking the 30 UTR region and hence
not targeted by the shRNA (Fig EV1F). Thus, the CC domain of
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Figure 1. Characterization of Trnp1 protein.
A Clustal alignment analysis of Trnp1 orthologs. Highly conserved and similar residues are shown in black and gray, respectively. Asterisks show 100% conserved
residues among all orthologs. Predicted disordered and structured regions are depicted with a red line and a black line, respectively. Cylinders represent alpha-helices,
and arrows represent turns.
B Analysis of the coiled-coil structure of Trnp1 using the prediction tool COILS.
C Immunostaining of endogenous Trnp1 and DAPI in P19 cells and E14 cortical cells at 1 day in vitro (div).
D Co-IP with anti-GFP and WB with anti-Trnp1 antibodies in lysates from P19 cells transfected with plasmids expressing Trnp1-GFP fusion protein and/or
Trnp1-IRES-RFP for 24 h. Mw (molecular weights): 55 kDa (black line); 35 kDa (blue line); 25 kDa (red line). Input: 0.1%; co-IP: all immunoprecipitated proteins.
E Representative phase-contrast images of in vitro phase separation of the recombinant proteins YFP (upper row) or Trnp1 (lower row) at the indicated concentration
in 50 mM Sorenson’s buffer (pH 7.6) containing 150 mM salt and 2 mM DTT with the crowding agent dextran or RNA when depicted.
Data information: Scale bars: 10 lm (C) and 50 lm (E). In Dextran and RNA condition 10 lm (E).
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Trnp1 is important to bind other CC containing proteins and
thereby contributes to retain Trnp1 in the nucleus, but it is not
required for self-interaction. In addition, the CC is necessary for
the rapid turnover of the protein (Fig 2D).
IDRs have been described as important regions for protein self-
assembly. As obvious candidates to determine the Trnp1 regions
that mediate homotypic interactions, truncated Trnp1 proteins
lacking the IDRs (Fig 2A) were tested for their capacity to interact
with a FLAG-tagged Trnp1 protein in a co-IP assay using anti-
FLAG antibodies. Deletion of either the N- or the C-terminal IDRs
abrogates their interaction with the FLAGTrnp1 protein (Fig 2E)
demonstrating that both IDRs are important for Trnp1 homotypic
interactions. Notably, however, deletion of the first N-terminal 16
aa (D1–16) still allowed binding to WT Trnp1. To test the behav-
ior of these deletion constructs in phase separation, we produced
the recombinant MBP-D1–16, MBP-D1–140 (C-term IDR), and
MBP-D95–223 (N-term IDR) Trnp1 proteins and tested their LLPS
capacity (Fig 2F). After MBP cleavage, using the same conditions
as for WT Trnp1 (Fig 1E), the size of droplets formed by the trun-
cated proteins was notably reduced (Fig 2F) compared to the full-
length WT Trnp1 (Fig 1E). When 25 lM of protein was used,
droplet size was reduced by 51.2, 79.8, and 73.8% for the D1–
16, D1–140, and D95–223 proteins, respectively, compared to
WT Trnp1 (Fig 2G). Thus, the D1–16 Trnp1 is strongly impaired
in its capacity to phase separate (Fig 2G), but can still interact
with WT Trnp1 (Fig 2E) indicating that these properties are not
identical. For all the other constructs, however, both properties
were impaired. Interestingly, the C-terminal IDR (D1–140) seems
to be affected by RNA addition forming fibrils in this condition,
while WT and the other deletion constructs do not (Fig 2F). All
tested constructs still form fibrils upon addition of the crowding
agent Dextran (Fig 2F). Taken together, these results show that
both, the N- and C-terminal IDRs, are crucial for the phase separa-
tion properties of Trnp1, with deletion of only the first 16 aa of
the N-terminal IDR already showing a strong reduction in the
LLPS capacity of Trnp1.
The most conserved part of the N-terminal IDR of Trnp1 is
required for its function in promoting proliferation in vitro
and in vivo
Given the pronounced defects in localization and phase separation
observed with the different truncation constructs, we examined
their effects in one of the main functions of Trnp1, namely to
promote proliferation and NSC self-renewal (Stahl et al, 2013). We
therefore stained E14 cortical cells for the proliferation marker Ki67
after transfection with the different Trnp1 constructs described
above (Fig 2A). While Trnp1, tagged or not with FLAG, significantly
increased the proportion of proliferating (Ki67+) GFP+ (i.e., trans-
fected) cells, compared to the cells expressing GFP only, already
removal of the first 16 N-term aa (D1–16) resulted in complete abro-
gation of this effect (Fig 2H). All larger deletions and the constructs
localizing predominantly in the cytoplasm were also no longer
promoting proliferation (Fig 2H). Conversely, the mutCCTrnp1 was
still able to significantly increase proliferation to a similar extent as
the WT Trnp1 (Fig 2H), indicating that the CC is not necessary to
maintain cells in a proliferating self-renewing state. Taken together,
the nuclear localization and the first 16 aa at the N-terminus are key
for Trnp1 promoting proliferation.
To test this also in vivo, we electroporated GFP only, Trnp1-
IRES-GFP, or D1–16 Trnp1-IRES-GFP constructs into the cerebral
cortex of E13 embryos and analyzed the distribution of GFP+ cells
(Fig 3A–C) 2 days later (E15) dividing a cortical column into five
equal-sized bins from ventricular to pial surface (Fig 3D). This ana-
lysis already gives an indication of changes in cell identity as prolif-
erating cells are located in bins 1–2, comprising the ventricular and
subventricular zones (VZ and SVZ). Indeed, upon Trnp1 expression
(Fig 3B) the proportion of GFP+ cells in bin 1, where mostly NSCs
are located, was almost double compared to the control (Fig 3D).
This was not the case, when D1–16 Trnp1 was expressed (Fig 3C
and D). Accordingly, also the proportion of proliferating (Ki67+)
cells (Fig 3E) and of Pax6+ NSCs (Fig 3F) among the GFP+ cells was
significantly increased when Trnp1, but not when D1–16Trnp1 was
◀ Figure 2. Structure–function analysis of Trnp1.A Scheme showing the different Trnp1 truncated/mutant constructs generated here and the region used for generating the Trnp1 antibodies. Note that antibody#1
works for immunofluorescence (IF) and WB while antibody#2 only works for WB.
B GFP and Trnp1 immunostaining with DAPI labeling in E14 cortical cells transfected for 24 h with plasmids expressing the different truncated/mutant forms of Trnp1
and GFP showing Trnp1 localization (indicated by arrows).
C Representative WB of cytoplasmic and nuclear-enriched fractions of P19 cells transfected with the different truncated/mutant forms of Trnp1 for 24 h. Hist1 and
actin serve as loading controls for nuclear and cytoplasmic fractions, respectively. The values under the anti-Trnp1 blots indicate the percentage of the signal relative
to the control set to 100% after normalization by a-actin (ImageJ quantification). The values under the anti-actin and anti-Hist1 blots indicate the percentage of the
signal considering that nuclear and cytoplasmic fractions together are 100%.
D Representative WB showing mutCC Trnp1 and D1–16 Trnp1 protein turnover in P19 cells 24 h after transfection in the presence of cycloheximide (CHX) for the time
indicated below in hours (h). GFP (half live:24 h) was used as a loading control.
E Co-IP with anti-FLAG magnetic beads and WB with anti-Trnp1 antibodies showing that FLAGTrnp1 interacts with the GFP-fusion and the D1–16Trnp1 proteins but
not with other truncated Trnp1 proteins indicating IDRs are crucial for Trnp1 homo-oligomerization. Samples were collected 24 h after transfection of P19 cells with
plasmids expressing the indicated proteins depicted in the panel.
F Representative phase-contrast images of in vitro phase separation of the recombinant D1–16Trnp1, D1140Trnp1, and D95–223Trnp1 proteins at the indicated
concentrations in 50 mM Sorenson’s buffer (pH 7.6) containing 150 mM salt and 2 mM DTT plus Dextran or RNA when indicated.
G Violin Dot Plots illustrating quantification of the area of single droplets. Each dot represents a droplet (N = 700) formed by the recombinant Trnp1, D1–16Trnp1,
D1140Trnp1, D95–223Trnp1 proteins at 25 lM concentration in a representative experiment of three repetitions under the conditions shown in (F).
H Histogram depicting the percent of proliferating (Ki67+) cells transfected for 24 h with plasmids expressing control (GFP) or Trnp1-IRES-GFP or its different
mutant/truncated forms-IRES-GFP in dissociated E14 cortical cells. Each dot in each condition represents an independent experiment. Biological replicates: GFP = 21;
Trnp1 = 15; FLAGTrnp1 = 10; mutCC = 5; D1–16 = 7; D1–1–56, D1–97, D1–140 = 3, D95–223 = 5, and D140–223 = 4.
Data information: Kruskal–Wallis test with Dunn’s post hoc test (G, H). **P < 0.01, ***P < 0.005. Mw: 55 kDa (black line); 35 kDa (blue line); 25 kDa (red line), 15 kDa
(green line), and 10 kDa (orange line). All experiments were repeated three independent times. Scale bars: 10 lm (B) and 50 lm (F) except for dextran and RNA
condition that is 10 lm (F).
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electroporated compared to control (Fig 3A and B). Interestingly,
Trnp1 affected NSC proliferation specifically, as transit-amplifying
progenitors (TAPs, also called basal progenitors) labeled by the
transcription factor Tbr2 rather decreased their proliferation. This
was measured by the number of cells found in S-phase using a short
pulse (1 h) of the DNA-base analog BrdU upon Trnp1 overexpres-
sion (Fig 3G). In contrast, D1–16 Trnp1 expression had the opposite
effect rather increasing TAP proliferation (Fig 3G), while decreasing
the proportion of Pax6+ NSCs compared to the control cells (Fig 3F).
Thus, also in vivo, deletion of the first 16 aa of the N-terminal IDR
of Trnp1 not only lost, but partially even antagonized the function
of Trnp1 in maintaining proliferation and retaining the NSCs
(Pax6+) in a self-renewing state.
Trnp1 interacts with proteins from nuclear membrane-
less compartments
To identify the molecular basis of Trnp1 function, we used mass
spectrometry (MS) to examine how and where its potential function
in phase separation may be relevant in the nucleus. After ensuring
that the addition of the FLAG at the N-terminus of Trnp1
(FLAGTrnp1) did not affect Trnp1 localization (Fig EV2A) and func-
tion (Figs 2H and EV2B–E), FLAG-tagged Trnp1 and non-tagged
Trnp1 as control were transfected in P19 cells and 24 h later the
DNAseI-treated nuclear extracts were immunoprecipitated using
anti-FLAG magnetic beads. The eluted proteins were identified and
quantified by label-free LC-MS/MS. Non-specific interactors were
discriminated by comparison with the proteins identified in the
untagged Trnp1 control samples.
We found 351 proteins to be specifically enriched [relative
change > 1.9 (the lowest relative change which could be con-
firmed); P value < 0.05] (Dataset EV1). Nine Trnp1 interactors were
randomly chosen for immunoprecipitation using specific antibodies
and WB using anti-Trnp1 antibody (Fig 4A) confirming the interac-
tions observed by MS. Most of these interactions were not RNA
dependent as treating nuclear extracts with Benzonase did not alter
their binding to Trnp1 (Fig 4A). Among the Trnp1 interactors, many
proteins are associated with nucleoli (36.18%), splicing (9.97%),
chromatin organization (4.55%), and cell cycle process (2.56%)
(Fig 4B). As deletion of the first 16aa had significantly reduced LLPS
and abolished the function of Trnp1, we repeated the above experi-
ment using the FLAGD1–16Trnp1 construct and the non-tagged D1–
16Trnp1 as negative control. Strikingly, interactors from all three
hubs were lost with very few significant interactions remaining
(Fig 4C). Thus, the highly conserved 1–16aa in the N-terminal IDR
of Trnp1 are crucial for interaction of Trnp1 with proteins of nuclear
MLOs in line with their role in LLPS and Trnp1 function.
The functional enrichment tool DAVID (Huang da et al, 2009)
revealed significantly enriched categories (in biological process,
cellular component, and Kyoto Encyclopedia of Genes and
Genomes, KEGG, pathway) for all Trnp1-interacting proteins identi-
fied by MS (Dataset EV2), such as GO terms associated with rRNA
processing and ribosome biogenesis, RNA splicing and mRNA
processing, chromatin modification, and transcription (Fig EV2F
and Dataset EV2 DAVID Biological process). Trnp1 interactors were
enriched for the KEGG pathways “Ribosome biogenesis”, “Ribo-
some”, “Spliceosome”, “RNA transport”, and “mRNA surveillance
pathway” suggesting a novel role of Trnp1 in these processes
(Dataset EV2 DAVID KEGG pathways). The GO term and KEGG
pathway analysis correlated very well with analysis using the
Search Tool for the Retrieval of Interacting Genes/Proteins
(STRING) 9.0 (http://string-db.org/) limiting this to experimentally
validated interactors. STRING analysis clearly shows three main
interaction modules: (i) proteins involved in nucleoli and ribosome
biogenesis, (ii) chromatin remodeling factors involved in condensa-
tion of chromatin, and (iii) RNA splicing proteins (Fig 4D). Thus,
Trnp1 interacts predominantly with proteins localized in nuclear
MLOs formed by phase separation (Banani et al, 2017).
Trnp1 protein surrounds nucleoli and interacts with components
of the granular component
Given the intriguing hubs of proteins interacting with Trnp1 high-
lighting nuclear MLOs, such as nucleoli, we used super-resolution
confocal microscopy to visualize the localization of endogenous
Trnp1 and the nucleolar proteins nucleophosmin (B23) and nucle-
olin (Ncl) (Fig 5A) in E14 cortical cells. Both nucleolar proteins are
located in the outer granular component (GC), the most external
nucleolar compartment formed by LLPS (Feric et al, 2016). Consis-
tent with its phase separation properties, Trnp1 is localized in small
condensates throughout the nucleus that are notably increased
surrounding the nucleoli overlapping with B23 and Ncl (Fig 5A, for
overlap, see line scan). Consistent with this spatial localization, Ncl
but not Fbl1 (localized in the dense fibrillary component (DFC))
was among the Trnp1 interactors identified by MS and confirmed by
immunoprecipitation for either Flag (Trnp1) or Ncl (Fig 5B). Inter-
estingly, the N-terminal truncated Trnp1 proteins lose their perinu-
cleolar localization and are also found within the nucleoli
(Fig EV3A, for overlap, see line scan). Although the localization of
the nucleolar protein Ncl was not impaired by these mutants
◀ Figure 3. The N-terminal IDR (first 16aa) of Trnp1 is important for promoting proliferation in vivo.A–C Micrographs showing examples of sections of E15 cerebral cortex 2 days after IUE of the plasmids indicated in (A–C) with magnifications showing the indicated
immunostainings. Scale bars: 100 and 20 lm for magnifications. Filled arrows show electroporated cells expressing Pax6 and Ki67 proteins. Open arrows show
electroporated cells negative for Pax6 and Ki67 staining. VZ: ventricular zone; SVZ: subventricular zone; IZ: intermediate zone; CP: cortical plate; V: ventricle.
D Bar and dot plot showing the distribution as percent of GFP+ cells/bin after IUE and staining as in A–C. A cortical column reaching from the ventricular surface
(bottom in A–C) to the pial surface (top in A–C) was divided into equal-sized bins with bin 1 at the ventricular surface and bin 5 at the pial surface.
E–G Bar and dot plots of the proportion of proliferating (Ki67+) cells (E), the number of NSCs (Pax6+), (F) and the proportion of proliferating (BrdU+) TAPs (Tbr2+)
(G) as in A–C showing a significant increase in proliferating NSCs upon Trnp1 IUE compared to control or D1–16Trnp1 proteins (E, F) and a significant decrease in
proliferating TAPs upon Trnp1 IUE and increase upon D1–16Trnp1 IUE compared to control (G) at E15, 2 days after IUE.
Data information: Biological replicates: in (D): control = 7; Trnp1 = 6; D1–16 = 8, in (E and F): control = 5; Trnp1 = 6; D1–16 = 7, in (G), control = 5; Trnp1 = 5; D1–
16 = 4 embryos from 2 to 4 different litters. Data are presented as median  IQR. Kruskal–Wallis test with Dunn’s post hoc test (D) and Mann–Whitney test (E–G).
*P < 0.05, **P < 0.01, ***P < 0.005.
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(Fig EV3A), we could observe that Fbl1 and ribosomal protein
Rpl26, both necessary for the biogenesis of mature ribosomes (Chen
& Huang, 2001; Robledo et al, 2008), were mislocalized upon high
expression of the Trnp1 N-terminal truncated proteins. While Rpl26
was mostly localized in the periphery rather than inside of nucleoli,
Fbl1 was diffuse (Fig EV3B and C), suggesting a role of Trnp1 in the
protein traffic between the nucleus and the nucleoli.
Given this localization and specific interaction with GC nucleolar
proteins, we were interested to determine the functional conse-
quences of raising Trnp1 levels on nucleoli structure and function.
Trnp1 regulates nucleoli, chromatin architecture, and
nuclear speckles
To explore the effects of Trnp1 on nucleoli, we first used TEM
(transmission electron microscopy) of P19 cells transfected with
GFP (as control) or Trnp1-IRES-GFP. One day after transfection,
GFP+ cells were isolated by FACS and processed for TEM (Fig 5C–
E). TEM revealed notable changes in the nucleoli upon Trnp1
expression (Fig 5C). Although the three compartments were
present, Trnp1 promoted an enlargement in the nucleolar interstice
in 51.4% of Trnp1-expressing cells (120 cells analyzed), while we
could not observe this phenotype in any of the control cells (132
cells analyzed) (Fig 5C; red arrows). These nucleolar spaces appear
around the two fibrillar components (DFC and FC), partially sepa-
rating them from the GC. We could also observe that condensed
chromatin blocks associated with the nuclear envelope and/or
nucleoli appear slightly larger in cells overexpressing Trnp1
compared to control cells (Fig 5D, red arrows). However, these
condensed chromatin blocks are not very frequent under both
conditions and most can be observed associated with the nuclear
envelope and/or nucleoli. Finally, TEM micrographs also show a
significant increase in the presence of dense strands within inter-
chromatin granules clusters (also called nuclear speckles) in cells
expressing Trnp1 compared to control cells (Fig 5E). While in the
control only 8% of cells contain clusters of interchromatin granules
with dense cord, this number is increased to 51.4% in Trnp1-expres-
sing cells (Fig 5E; red arrows). Notably, all cells presenting an
enlargement in the nucleolar interstice also contain clusters of inter-
chromatin granules with dense cords, suggesting a common role of
Trnp1 in both phenotypes. Trnp1 expression does not affect the
levels of nucleolar proteins (Fig 5F), indicating that the effects of
Trnp1 on the nucleolus are dependent rather on Trnp1’s structural
function than its potential role in gene expression (Stahl et al, 2013)
or regulating nucleolar protein levels. The changes in the architec-
ture of condensed chromatin, nuclear speckles, and nucleoli after
Trnp1 manipulation are intriguing as all these MLOs are formed by
LLPS and are rich in Trnp1 interactors as observed by MS (Fig 4D).
Thus, Trnp1 may play a role in regulating several nuclear MLOs
simultaneously.
Trnp1 regulates the dynamics of nucleoli during cell cycle and M
phase length
Given that Trnp1 modifies the heterochromatin associated with the
nucleolus and also interacts with many proteins related to nucleolar
function, including proteins essential for nucleolus biogenesis such
as UBF1 (Grob & McStay, 2014) and Ncl (Ma et al, 2007; Ugrinova
et al, 2007), we examined if Trnp1 may regulate nucleoli dynamics
during cell cycle. To visualize if Trnp1 is responsible of changes in
nucleoli assembly and disassembly, P19 cells were transfected with
plasmids expressing Fbl1-GFP fusion protein (for nucleoli visualiza-
tion) together with RFP alone, Trnp1-IRES-RFP, or D1–16Trnp1-
IRES-RFP. Imaging started 22 h after transfection with confocal
images taken every 10 min for a period from 16 to 72 h (Fig 6A). As
expected during M-phase (Angelier et al, 2005), the large GFP-Fbl1
foci disappeared for some time and re-appeared as small foci that
then fuse and form again larger structures (Fig 6A). To quantify the
effects of Trnp1 on nucleoli, we measured the number, size, and
total area of GFP-Fbl1 foci per cell over time starting 180 min before
and finishing 180 min after separation of sister chromatids in M-
phase (t = 0) (Fig 6A–C). While Trnp1 expression did not affect the
number of GFP-Fbl1 foci (Fig 6B), it significantly increased their
size (Fig 6A) and the total area of GFP-Fbl1 foci per cell (Fig 6C),
indicating that Trnp1 expression increases the size of the existing
nucleoli, but not the formation of new ones.
We further noted that Trnp1 shortened the period of GFP-Fbl
disappearance (Fig 6A and C), while nucleoli re-assembly was not
affected (Fig 6C). This prompted us to explore the dynamics of the
cell cycle and especially the length of M-phase, that is normally
closely coordinated with nucleoli dynamics. To do so, we expressed a
H2B-Venus fusion protein to monitor mitosis from the condensation
of the chromatin starting in prophase to the de-condensation of chro-
mosomes at the end of telophase (Fig 6D). Interestingly, these experi-
ments showed that Trnp1 expression significantly shortened the
duration of M-phase (Trnp1 = 54.3 min) compared to control trans-
fected cells (RFP = 70.8 min) (Fig 6E). Synchronizing P19 cells and
measuring the different mitotic phases at different time points by
DAPI confirmed the specific effect of Trnp1 on entry into M-phase as
Trnp1 transfected cells left interphase and entered prophase signifi-
cantly faster than the controls (Fig 6F). Mitotic index analysis in the
E15 developing cortex 24 h after in utero electroporation (IUE)
of plasmids expressing GFP as control, Trnp1-IRES-GFP, or the
D1–16Trnp1-IRES-GFP corroborates the faster M-phase provoked by
◀ Figure 4. Trnp1 interacts with proteins involved in ribosomal biogenesis, splicing, and chromatin remodeling.A WB showing co-IP performed with the antibodies indicated on top of the lanes in nuclear lysates treated with the nucleases indicated to the right of the panel. P19
cells were transfected with plasmids expressing FLAGTrnp1 for 24 h and immunoblotted with anti-Trnp1 antibodies. As negative control, no antibody was added to
the co-IP.
B, C Volcano plot showing the mean difference in the protein iBAQ between FLAGTrnp1 (B) and FLAGD1–16Trnp1 (C) interacting proteins vs. control plotted against the
P-value. Proteins used to experimentally confirm the MS results are indicated with squares and the protein name in (B, C).
D STRING analysis of Trnp1 interactors (B). The disconnected nodules are not shown. Protein cluster has been color coded (green for chromatin association, red for
RNA splicing, blue for proteins involved in nucleolus function, and light yellow for the rest).
Data information: In panels (B and C), black dotted lines indicate the fold change (FC > 1.9) and the significance cutoff (t test; P > 0.05). Each dot represents a protein.
Proteins participating in different functions have been color coded (yellow for chromatin association, green for cell cycle, red for RNA splicing, blue for proteins involved
in nucleolus function, and black for the rest).
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Figure 5. Trnp1 changes the architecture of nucleolus, condensed chromatin, and nuclear speckles.
A Super-resolution confocal image of endogenous nucleophosmin (B23), nucleolin (Ncl), and Trnp1 proteins in E14 cortical cells at 1div. The yellow line indicates the
position of the intensity line scan plot (below confocal panels) measuring the gray value of each staining (Trnp1 = gray; Ncl = purple and B23 = green). Scale bars,
5 lm.
B Co-IP experiments with lysates from P19 cells expressing FLAGTrnp1 for 24 h. IPs and WB with the antibodies indicated show interaction between Trnp1 and Ncl,
but not with Fbl1, consistent with the MS data.
C–E Ultrastructural analysis depicting in the nucleolus (arrows for nucleolar interstice) (C), condensed chromatin blocks (arrows) (D) and nuclear speckles or
interchromatin granule clusters (arrows for dense cords) (E) in the nucleus of P19 cells transfected with plasmids expressing Trnp1-IRES-GFP or GFP in control cells
FACS sorted and fixed 24 h after transfection. Scale bars, 2 lm (D) and 1 lm (C and E). Nu: nucleolus; G: granular component; D: dense fibrillar component;
FC: fibrillar center; C: condensed chromatin.
F WB of lysates from P19 cells transfeted for 24 h with plasmids expressing GFP only or Trnp1-IRES-GFP with antibodies indicated.
Data information: All experiments were done at least in duplicate.
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Trnp1, but not D1–16Trnp1 (Fig 6G). Taken together, these results
demonstrate a role of Trnp1 in the disassembly of nucleoli, which
occurs in prophase, but not in their re-assembly occurring during end
of telophase and beginning of G1. This correlated with the faster
progression into prophase, suggesting that Trnp1 coordinates nucleo-
lar dynamics and mitosis progression. Consistent with the data
shown above, none of these effects were observed in cells transfected
with D1–16Trnp1 further demonstrating that this small region of the
N-terminal IDR is crucial for Trnp1 function regulating M-phase
length and affecting nucleoli size and dynamics.
Trnp1 regulates the size of nucleoli and heterochromatin in the
developing cerebral cortex in vivo
As the above data were obtained upon overexpression of Trnp1 in
P19 cells in vitro, a cell type not expressing endogenous Trnp1, we
proceeded to examine the novel role of Trnp1 in regulating nuclear
MLOs in the developing cerebral cortex in vivo. Staining for the
nucleolar proteins B23 and Fbl in sections of E15 cortex was notably
more prominent in NSCs in the VZ, where endogenous Trnp1 is
expressed, compared to the TAPs localized in the SVZ that lack
endogenous Trnp1 (Stahl et al, 2013; Fig EV4A). To analyze the
specific role of Trnp1 on nucleoli, we electroporated plasmids
expressing GFP, Trnp1-IRES-GFP, D1–16Trnp1-IRES-GFP, and the
previously described shRNA against Trnp1 and its specific control,
both expressing also GFP (Stahl et al, 2013) at E13 and analyzed the
nucleoli (using Ncl staining) in GFP+ cells 2 days later (Fig 7A–C, G
and H). We focused our analysis on NSCs in the VZ (bipolar cells
with the morphology of radial glial cells that were typically Pax6+)
and above the VZ, referred to as non-VZ, focusing on multipolar
TAPs that were typically Tbr2+ (Fig EV4B–D), excluding the
neurons in the cortical plate. First, we measured the size of the
nucleus that was not affected by Trnp1 overexpression compared to
control cells (Fig 7D). Quantification of nucleoli size and number by
Ncl immunostaining in GFP-expressing control cells (Fig 7A)
revealed, however, significant differences in both, number (Fig 7E)
and size (Fig 7F) of nucleoli in the VZ compared to the non-VZ,
correlated with the endogenous levels of Trnp1 (high in VZ, low in
non-VZ). Upon Trnp1 overexpression (Fig 7B), we also found a
significant increase in nucleoli size (Fig 7F), but not their number
(Fig 7E), in the non-VZ where endogenous Trnp1 is low. This is
consistent with the effects seen in P19 cells (that do not express
endogenous Trnp1) with Trnp1 overexpression increasing size of
nucleoli, but not regulating formation of new nucleoli (Fig 6B and
C). Conversely, D1–16Trnp1 expression (Fig 7C) significantly
reduced the number (Fig 7E) and size (Fig 7F) of nucleoli in the VZ,
but not the non-VZ, thereby acting as a dominant-negative form in
this context. Importantly, knock-down of Trnp1 (Fig 7G and H) did
not affect the number of nucleoli (Fig 7J), but resulted in reduction
in nucleolar size in NSCs in the VZ (Fig 7K), corroborating that
endogenous Trnp1 in VZ cells increases nucleolar size in vivo.
Surprisingly, Trnp1 knock-down increased nuclear size (Fig 7I), but
as nucleoli size was normalized to the nuclear area, this cannot
explain its effects on nucleolar size.
Trnp1 affects size and function of several nuclear MLOs
Given that Trnp1 interacts with protein hubs of other nuclear MLOs,
such as splicing and repressive chromatin complexes, and most of
these interactions are lost for the D1–16Trnp1 we aimed to deter-
mine whether Trnp1 could also be responsible for the modification
of the architecture of any of these MLOs in vivo. As Trnp1 localizes
to euchromatin surrounding the DAPI-rich areas of heterochromatin
(Stahl et al, 2013; Fig EV4E), we used the same IUE sections
described above (Fig 7A–C) and examined the condensed chromatin
spots visible in DAPI staining (Fig 8A–C). The number and size of
heterochromatin spots in GFP-expressing control cells was similar
in VZ and non-VZ (Fig 8D and E). In Trnp1 electroporated cells, we
could not observe differences in the number of DAPI-rich spots
(Fig 8D). The D1–16Trnp1 mutant, however, decreases the number
of heterochromatin spots compared to control cells (Fig 8D), indi-
cating that this truncated form of Trnp1 behaves as a dominant
negative. As also observed for nucleoli, Trnp1 overexpression
promotes a significant increase in the size of heterochromatin spots
(Fig 8E), while IUE of the D1–16Trnp1 again acts as a dominant
negative (Fig 8E). Thus, Trnp1 overexpression in the developing
cerebral cortex in vivo affects the size of two MLOs simultaneously
increasing nucleoli and condensed chromatin spots.
As Trnp1 also affected nuclear speckles when overexpressed in
P19 cells, we next examined the role of Trnp1 in regulating alterna-
tive splicing in cerebral cortex NSCs in vivo, using the above
described shRNA constructs (Fig 7G and H). In order to determine
the earliest changes not yet affected by the altered cell type composi-
tion, we collected GFP+ cells 1 day after IUE with shcontrol or
shTrnp1 constructs by fluorescence-activated cell sorting (FACS)
(Fig EV4F). RNA sequencing showed a total of 237 differentially
◀ Figure 6. Trnp1 modulates nucleoli disassembly and M-phase duration in vitro.A Representative time-lapse sequence of GFP-Fbl1 in P19 cells expressing the plasmids indicated defining t = 0 when the chromatids separate (anaphase).
B, C Analysis of the number (B) and the total area (C) of the GFP-Fbl1 foci in P19 cells expressing the constructs indicated for a period of 360 min. Bandwidth represents
SEM, and gray areas represent time points with significant differences between the control and the Trnp1-expressing conditions. The D1–16Trnp1 expression does
not show any statistical difference compared to the control condition.
D Representative time-lapse sequence including one mitosis of H2B-Venus in P19 cell expressing the indicated constructs.
E Volcano Plot illustrating the length of M-phase from condensation to de-condensation of chromosomes in minutes. Each dot represents an individual cell from 3
different biological replicates. GFP = 61 cells, Trnp1 = 62 cells, and D1–16Trnp1: 40 cells.
F Bar graph showing the percentage of cells expressing Trnp1-IRES-GFP or GFP as control in each phase of the mitosis (indicated in different color) at different times
after release from synchronization in G2. 100 cells per condition and time were analyzed.
G Bar and dot plots depicting the proportion of GFP+ NSCs (Pax6+) in mitosis (pHH3+) showing a significant decrease 24 h after Trnp1 compared to control IUE.
N = 4 brains from embryos of 2 to 3 different litters.
Data information: Imaging started 22 h after transfection with confocal images taken every 10 min for a period of 16–72 h. Time 0: chromatid separation. Results are
shown as mean  SEM (B and C) or as median  IQR (E–G). Mann–Whitney test (B, C, E, F) and Kruskal–Wallis test with Dunn’s post hoc test (G). *P < 0.05; **P < 0.01;
***P < 0.005.
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regulated splicing events and a bias toward a decrease in exon skip-
ping events (Fig 8F), corroborating an influence of Trnp1 levels on
alternative splicing.
Given these functional changes along with the structural changes
we observed above, we were keen to determine whether function of
nucleoli was also affected. Toward this end, we used the OPP-puro
click assay to determine the translation rate in P19 cells by quantify-
ing cellular fluorescence using microscopy (Fig 8G) or FACS
(Fig 8H). Indeed, Trnp1 expression significantly increased transla-
tion (Fig 8G and H) and we could show that this was not due to an
increase in ribosomal RNA transcription that was not affected by
Trnp1 (Fig 8I). Notably, the expression of D1–16Trnp1 also shows
an increase in the rate of translation compared to the control cells,
but not as high as the one produced by the expression of the WT
Trnp1 protein (Fig 8G and H), indicating that the first 16 amino
acids are also relevant for this function. This result together with
MS analysis showing interaction with many proteins involved in
ribosome biogenesis suggests that Trnp1 probably regulates transla-
tion by regulating the biogenesis of new ribosomes in the nucleoli.
Taken together, Trnp1 levels not only regulate size and architecture,
but also function of several nuclear MLOs.
Discussion
Here, we uncovered the molecular function of Trnp1 interacting
with protein hubs associated with several nuclear MLOs, nucleoli,
nuclear speckles, and condensed chromatin, mostly via its N-term-
inal IDR. We found that Trnp1 regulates the size, architecture, and
function of these MLOs and is thus the first nuclear protein regulat-
ing these MLOs in a concerted manner, thereby orchestrating their
functions. Based on the capacity of Trnp1 to phase separate and its
localization surrounding the nuclear MLOs, in particular its enrich-
ment around the nucleoli, we propose a model with Trnp1 levels
easing the transition between the MLOs and the surrounding nucleo-
plasm as depicted in Fig 9.
Structure–function analysis of Trnp1
Trnp1 has a central structured region flanked by two IDRs at the N-
and C-terminus. IDR proteins have been described to act as “hubs”
in protein interaction networks (Dunker et al, 2001; Darling &
Uversky, 2018) assembling specific proteins together in MLOs
(Banani et al, 2017) by a LLPS mechanism (Damianov et al, 2016;
Feric et al, 2016; Strom et al, 2017). To do so, IDR proteins have to
initiate low-affinity transient interactions with many other proteins
and also form homo-oligomers simultaneously (Li et al, 2012;
Banani et al, 2017). Trnp1 does indeed both—interact with many
proteins associated with MLOs and with itself. Our structure–func-
tion analysis showed that Trnp1 IDRs are important for both types
of interactions. Both IDRs are needed for the homo-oligomerization
capacity of Trnp1 and also exert effects on its capacity to phase
separate. Interestingly, the highly conserved first 16 N-terminal
amino acids of Trnp1 are most critical for LLPS since droplet size is
strongly reduced when this part is deleted. Moreover, most of the
interactions of Trnp1 with other proteins are lost upon deletion of
this stretch of amino acids. Accordingly, deletion of these N-term-
inal 16 aa also abrogates the effects of Trnp1 on nucleolar and hete-
rochromatin architecture as well as its function in speeding up M-
phase entry and cell cycle progression in vitro and in vivo. Interest-
ingly, in vivo this Trnp1 truncation even exhibits some degree of
dominant-negative effects. While Trnp1 increases the proportion of
NSCs, the expression of D1–16Trnp1 reduces it, while increasing
TAP proliferation. Likewise the effects of Trnp1 on increasing nucle-
olus size were rather the opposite with D1–16Trnp1 reducing size
and number of nucleoli and heterochromatin spots. Therefore, this
small region of the N-terminal IDR exerts powerful effects in virtu-
ally all functional aspects of Trnp1 explored here.
Although this small region is composed by LC amino acids as
part of the N-terminal IDR, it is 100% conserved among all Trnp1
orthologs in line with its importance for Trnp1 function. It has been
shown that post-translational modifications (PTMs) play an impor-
tant role in the conservation of IDRs during evolution (Narasumani
& Harrison, 2018) and their capacity to phase separate (Owen &
Shewmaker, 2019). As several of these N-terminal aa of Trnp1 can
be post-translationally modified, mostly by phosphorylation and
oxidation, such modifications may be also crucial for the fast regula-
tion of Trnp1 function. It is also well conceivable that deletion of
these 16aa affects the secondary and tertiary structure of Trnp1.
This may also explain the partial dominant-negative effects
observed by the expression of this deletion construct mostly in vivo
in the presence of endogenous Trnp1. In this regard, it is also impor-
tant to note that the D1–16Trnp1 can still interact with WT Trnp1
and may thereby exert dominant-negative effects only in vivo in the
◀ Figure 7. Trnp1 regulates size of nucleoli in vivo.A–C Micrographs showing GFP (green: electroporated cells (A–C)) and Ncl (gray: nucleoli (A0–C0)) immunostaining of E15 cerebral cortex 2 days after IUE with plasmids
indicated. Position of magnifications shown on the right side is depicted by a white square. V = ventricle; VZ: ventricular zone. Yellow dotted shapes show
examples of nucleoli in nuclei of electroporated cells from the VZ and the non-VZ. Scale bars: 20 and 10 lm for magnifications.
D–F Violin plots depicting the nuclear size (D) nucleoli number (E) and nucleoli size (F) from cells electroporated as in A–C with the constructs and the areas indicated
on the x-axis. Note that in Trnp1, but not D1–16Trnp1, overexpression is sufficient to significantly increase nucleolar size in the non-VZ (where most cells lack
endogenous Trnp1). N = 10 cells per region from 6 different control and Trnp1-IRES-GFP electroporated embryos and N = 15 per region from 3 to 4 different
D1–16Trnp1-IRES-GFP electroporated embryos from at least 4 litters.
G, H Micrographs showing GFP (green: electroporated cells), Pax6 (magenta for NSCs), and Ncl (gray for nucleoli) immunostainings in sections of E15 cerebral cortex
2 days after IUE with plasmids indicated. Scale bar: 20 lm. Yellow dotted shapes show examples of nuclei in electroporated, and yellow nondotted shapes show
examples of nuclei non-electroporated cells from the VZ and the non-VZ.
I–K Violin plots depicting the nuclear size (I), nucleoli number (J) and nucleoli size (K) from cells electroporated as in (G, H) with the constructs and the areas indicated
on the x-axis. Note that Trnp1 knockdown significantly decreases nucleolar size in the VZ (where most cells express endogenous Trnp1). N = 10 cells per region
from 7 embryos per condition from at least 4 litters.
Data information: Each dot represents a cell. Boxes in violin plots represent median  IQR. Kruskal–Wallis test with Dunn’s post hoc test. *P < 0.05, **P < 0.01,
***P < 0.005.
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◀ Figure 8. Trnp1 co-regulates the function of several nuclear MLOs.
A–C Micrographs of sections of E15 cerebral cortex 2 days after IUE with plasmids and magnifications indicated. V = ventricle; VZ: ventricular zone. Scale bars: 20 and
10 lm for magnifications. Yellow dotted shapes show examples of heterochromatin spots in nuclei of electroporated cells from the VZ and the non-VZ.
D, E Violin plots depicting the number (D) and size (E) of condensed chromatin spots from cells electroporated as in (A–C). Note that Trnp1 overexpression is sufficient
to significantly increase the size of condensed chromatin spots, while the D1–16Trnp1 acts as a dominant negative reducing the number and size of
heterochromatin spots. N = 10 cells per region from 5 embryos for GFP and Trnp1 and 8–15 cells from 4 embryos for D1–16Trnp1 of at least 4 litters. Each dot
represents a cell. Results are shown as median  IQR.
F Summary of the splicing changes observed in GFP+ cells isolated by FAC sorting from E14 cerebral cortex 24 h after IUE with plasmids expressing the shRNA
against Trnp1 and its control as determined by RNA-seq analysis. The number of events per category is shown in the bar. SE, skipped exon; RI, intron retention;
MXE, mutually exclusive exon; A5SS, alternative donor site; A3SS, alternative acceptor site.
G, H Translation assay using OPP-click reaction in P19 cells transfected for 24 h with GFP, Trnp1-IRES-GFP, or D1–16Trnp1-IRES-GFP plasmids and analyzed by
immunofluorescence (G) or FAC sorting (H). Graph in (G) is representative from three different biological replicates. Each dot represents a cell. Control = 102;
Trnp1 = 126; D1–16Trnp1 = 97. Graph in (H) shows analysis of 2,000 transfected cells from 1 representative experiment with 2 biological replicates for control and
3 biological replicates for Trnp1 and D1–16Trnp1 conditions. The same FAC sorting experiment was repeated two more times. The dotted vertical line shows the
mean of the OPP click signal for each condition.
I Bar and dot plots depicting rRNA transcription for the 18S, 28S, 45S, and 47S measured by qPCR in P19 cells transfected for 24 h with plasmids expressing
Trnp1-IRES-GFP or D1–16Trnp1-IRES-GFP compared to control cells expressing GFP. Each dot represents a biological replicate. N = 4 for each condition.
Data information: Kruskal–Wallis test with Dunn’s post hoc test. P-values *P < 0.05; **P < 0.01; ***P < 0.005.
Figure 9. Model of Trnp1 function.
See manuscript text for details.
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presence of endogenous Trnp1, but not in P19 cells in the absence
of endogenous Trnp1.
Beyond its IDRs, Trnp1 has a structured alpha helix region,
containing a CC domain, which also promotes heterotypic interac-
tions as many of Trnp1 interactors are also proteins with a CC
domain. In fact, Trnp1 was first identified as an interactor of the CC
containing E3 ubiquitin ligase TMF/ARA160 (Volpe et al, 2006),
and accordingly, we found that this conserved part is important to
regulate Trnp1 protein levels via proteasome. Trnp1 protein levels
are key in the development of embryonic cortex, with even slight
differences exerting profound effects on expansion of stem and
progenitor cell types needed for brain folding (Stahl et al, 2013;
Martinez-Martinez et al, 2016). Thus, our data add a new mode to
regulate Trnp1 levels to the previously reported transcriptional regu-
lation (Stahl et al, 2013; de Juan Romero et al, 2015).
Trnp1 regulates nucleolar architecture and function and M-
phase length
A particularly important nuclear MLO accumulating proteins of
entire pathways and including specific genes inside its boundaries is
the nucleolus. Our proteome analysis showed that Trnp1 interacts
with many nucleolar proteins with important roles for its function,
biogenesis, and cell cycle progression. Furthermore, we could
demonstrate that Trnp1 regulates nucleolar dynamics, architecture,
and translation, supporting the idea that Trnp1 is a new regulator of
this nuclear MLO. During interphase, the different steps for ribo-
some biogenesis are responsible for the three sub-compartments
(GC, DFC, and FC) nucleolar organization (Tchelidze et al, 2019).
We found that Trnp1 concentrates in the surrounding of the nucleo-
lus overlapping with the GC domain-containing Ncl, one of the most
abundant nucleolar proteins and one of the Trnp1 interactors. This
localization and the fact that Trnp1 interacts with many other nucle-
olar proteins, including ribosomal proteins transported from the
cytoplasm (Thomson et al, 2013), inspire the hypothesis that Trnp1
could be involved in the regulation of the protein traffic between
nucleoplasm and nucleoli. Indeed, staining for the ribosomal protein
Rpl26 showed its accumulation surrounding the nucleoli upon
expression of the Trnp1 constructs with deletion of the N-terminal
IDR (Fig EV3B and C). Our MS analysis shows loss of most interac-
tion partners after deletion of the N-terminal 16 aa, suggesting that
this may hamper the transport into the nucleolus. We would there-
fore suggest that Trnp1 could control ribosome biogenesis and the
rate of translation by interacting with nucleolar proteins and thereby
ease the protein traffic into the nucleolus.
We showed here by overexpression and knock-down experiments
in vivo that higher Trnp1 levels increase and lower levels decrease
the size of nucleoli in the developing cerebral cortex. Moreover,
increasing Trnp1 levels also increases the rate of translation, in
agreement with previous work showing that the size of the nucleolus
is positively correlated with the ribosome production (Derenzini
et al, 1998). The function of Trnp1 in transport of ribosomal proteins
into the nucleolus and hence ribosomal biogenesis could also be at
least partly responsible for the effects of Trnp1 in promoting prolifer-
ation as increased production of ribosomes has also been correlated
with increased proliferation rates (Lempiainen & Shore, 2009).
Like several other nuclear MLOs, nucleoli disassemble as cells
enter mitosis (Dundr et al, 2000) and then reassemble at the end of
mitosis to ensure survival of the daughter cells. Using continuous
live imaging, we observed that Trnp1 increased the speed of nucle-
oli disassembly but not re-assembly, an effect that is correlated with
a faster mitosis. Although the cells expressing Trnp1 displayed a
normal progression along the different phases of mitosis, we found
that the faster mitosis progression was predominantly due to faster
entry of cells into M-phase and a shorter prophase, when nucleoli
are disassembled. In contrast, telophase was not affected consistent
with Trnp1 not regulating the speed of nucleolus re-assembly at the
end of mitosis. These data indicate that Trnp1 co-regulates at the
same time the speed of the initial phases of mitosis and the disas-
sembly of nucleoli.
Trnp1 could do that by different means. One important function
of the nucleolus is to sequester key effector molecules away from
their site of action (Rai et al, 2018). Several of these effectors are
proteins related to progression of cell cycle such as enzymes respon-
sible of PTM of cell cycle proteins (Boisvert et al, 2007). Trnp1, by
regulating the nuclear-nucleolus traffic of these proteins, could regu-
late their liberation from the nucleoli promoting a faster entry of
cells into mitosis and, as consequence, a faster disassembly of
nucleoli. Thus, by regulating nucleolar protein trafficking Trnp1
could also regulate cell cycle progression and nucleolus disassem-
bly. Alternatively, or in addition, Trnp1 may also regulate these
processes by regulating the time that chromosomes need to conden-
sate, an essential step for nucleolus disassembly (Boisvert et al,
2007). Indeed, we could show here that Trnp1 interacts with
proteins essential for chromosome condensation such as histones;
AKAP8; mitotic kinases like Plk1; and the Condensin complex
proteins Ncapd2, Ncapg, and Ncaph. The nuclear protein AKAP8 is
necessary to recruit HDAC3 at the onset of mitosis and promote the
de-acetylation of histone H3 which brings the Condensin complex to
the chromatin (Han et al, 2015). Plk1, localized in the chromosomes
axes, promotes the phosphorylation of the Condensin complex, a
process necessary for the correct chromosomes condensation in
prophase (Abe et al, 2011). Thus, by regulating the function and/or
localization of these proteins Trnp1 could control the speed of chro-
mosome condensation and as consequence the speed of nucleoli
disassembly.
These effects of Trnp1 on M-phase length are particularly rele-
vant in NSC differentiation, since prolongation of M-phase has
been shown to promote differentiation of NSCs in the developing
cortex (Pilaz et al, 2016). This suggests that shortening of M-phase
would result in reduced NSC differentiation and increased self-
renewal, as observed when Trnp1 levels are increased, here and in
(Stahl et al, 2013).
Trnp1 affects several nuclear MLOs
Trnp1 also affects the architecture of heterochromatin spots and
nuclear speckles, other well-described nuclear MLOs that are also
disassembled during M-phase (Spector & Lamond, 2011), con-
firming the importance of Trnp1 function in proliferating cells.
This observation is further supported by our MS data showing
Trnp1 to interact with many proteins responsible for chromatin
condensation and heterochromatin formation, such as all the
proteins of the NuRD, PRC2 and PRC1 complex (Laugesen &
Helin, 2014; Basta & Rauchman, 2015), and several proteins local-
ized in the nuclear speckles. Since Trnp1 is not part of these
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complexes but, like for nucleoli, is localized surrounding these
structures (Fig 9), we propose that Trnp1 can also play an impor-
tant role concentrating and assembling these complexes in speci-
fic micro-domains in the nucleus and facilitate their biochemical
reactions. In fact, we have shown that Trnp1 regulates gene
expression (Stahl et al, 2013), alternative splicing and protein
translation, confirming the biological importance of Trnp1 for the
function of these nuclear MLOs. Trnp1 has thus a rather unique
role in co-regulating these MLOs. A recent knock-down screening
of MLO components highlighted that few hits regulate 2 or more
MLOs (Berchtold et al, 2018). These components were all located
within the respective MLOs. Trnp1 is rather unique by surround-
ing the MLOs it affects and thereby regulating their architecture
and function (Fig 9).
Taken together, these data support a close link between LLPS
properties, interactors, and the functional effects of Trnp1 as an
interactor hub in the regulation of nuclear MLOs. Importantly, we
show that the effects of Trnp1 on maintaining NSC in a self-
renewing state are accompanied by a significant modification in the
architecture (nucleoli, heterochromatin) and function (splicing) of
different nuclear MLOs also in vivo, confirming the biological impor-
tance of this new function of Trnp1. As Trnp1 is expressed in many
stem cells of other organs during embryogenesis (Metzger, 2011)
and various cancer cells (Uhlen et al, 2017), its novel role in co-
regulating nuclear MLOs and M-phase progression may have a
broader relevance beyond the developing nervous system.
Materials and Methods
Droplet assay in vitro
For droplet formation assay, all the purified proteins were diluted to
100 mM in storing buffer before diluting in droplet buffer (50 mM
Sorenson’s buffer (pH 7.6) containing 150 mM salt and 2 mM DTT)
to the concentrations indicated in the Figures and phase separation
was induced by addition of acTEV protease (Invitrogen) at 25°C.
RNA or Dextran was used when explicitly mentioned in the Figures.
Phase-contrast was used to image the droplets. YFP was used as a
negative control for droplet formation. The experiments were
repeated three independent times. Note that phase separation prop-
erties, i.e., critical concentration for droplet formation, differ slightly
between different protein preparations. Quantification of droplets
was counted manually using FIJI/ImageJ software.
Mass spectrometry
For LC-MS/MS purposes, desalted peptides were injected in an Ulti-
mate 3000 RSLCnano system (Thermo) and separated in a 15-cm
analytical column (75 lm ID with ReproSil-Pur C18-AQ 2.4 lm from
Dr. Maisch) with a 50 min gradient from 5 to 60% acetonitrile in
0.1% formic acid. The effluent from the HPLC was directly electro-
sprayed into a LTQ-Orbitrap mass spectrometer (Flag-Trnp1 vs.
Trnp1 Ref399) or a Q Exactive HF (Flag-delta 1–16_Trnp1 vs. delta
1–16_Trnp1 Ref1644).
For LTQ-Orbitrap measurements, the instrument was operated in
data-dependent mode to automatically switch between full scan MS
and MS/MS acquisition. Survey full scan MS spectra (from m/z 300
to 2,000) were acquired in the Orbitrap with resolution R = 60,000
at m/z 400 (after accumulation to a “target value” of 500,000 in the
linear ion trap). The six most intense peptide ions with charge states
between 2 and 4 were sequentially isolated to a target value of
10,000 and fragmented in the linear ion trap by collision-induced
dissociation (CID). All fragment ion spectra were recorded in the
LTQ part of the instrument. For all measurements with the Orbitrap
detector, three lock-mass ions from ambient air were used for inter-
nal calibration. Typical MS conditions were as follows: spray volt-
age, 1.5 kV; no sheath and auxiliary gas flow; heated capillary
temperature, 200°C; normalized CID energy 35%; activation
q = 0.25; and activation time = 30 ms.
For Q Exactive HF measurements, the mass spectrometer was
operated in data-dependent mode to automatically switch between
full scan MS and MS/MS acquisition. Survey full scan MS spectra
(from m/z 375 to 1,600) were acquired with resolution R = 60,000
at m/z 400 (AGC target of 3 × 106). The 10 most intense peptide
ions with charge states between 2 and 5 were sequentially isolated
to a target value of 1 × 105 and fragmented at 27% normalized
collision energy. Typical mass spectrometric conditions were as
follows: spray voltage, 1.5 kV; no sheath and auxiliary gas flow;
heated capillary temperature, 250°C; and ion selection threshold,
33,000 counts.
MaxQuant 1.5.2.8 was used to identify proteins and quantify by
iBAQ with the following parameters: Database, Uniprot_Mmuscu-
lus_UP000000589_10090_151030; MS tol, 10 ppm; MS/MS tol,
0.5 Da (Orbitrap LTQ) or 10 ppm (QExactive); Peptide FDR, 0.1;
Protein FDR, 0.01; Min. peptide Length, 5; Variable modifications,
Oxidation (M); Fixed modifications, Carbamidomethyl (C); Peptides
for protein quantitation, razor, and unique; Min. peptides, 1; Min.
ratio count. 2. Identified proteins were considered as interaction
partners, if their MaxQuant iBAQ values displayed a greater than
1.9-fold change enrichment and P-value 0.05 (ANOVA) when
compared to the control.
Statistical and bioinformatics analysis was performed with the
Perseus software (Tyanova et al, 2016) (version 1.5.6.0), Microsoft
Excel, and R statistical software. Proteins that were identified in the
decoy reverse database or only by site modification were not consid-
ered for data analysis. We also excluded potential contaminants.
Data were further filtered to make sure that identified proteins
showed expression in all biological triplicates and missing values
were imputed on the basis of normal distribution. Mean log2 ratios
of biological triplicates and the corresponding p values were visual-
ized with volcano plots. We used t-test for binary comparisons and
SAM with FC > 1.9 and P < 0.05 for the assessment of t-test results
in volcano plot. The DAVID webserver (Version 6.8, LHRI & DAVID
Bioinformatics) was employed for Gene Ontology enrichment analy-
sis and KEGG pathway analysis (Huang da et al, 2009). Trnp1 inter-
actors were also subjected to STRING analysis using the web-tool
available via http://string-db.org/ (Jensen et al, 2009). Figure 4D
shows the confidence view with the active prediction methods
“Experiments”, “Databases”, and highest confidence score (0.9)
hiding disconnected nodes. A Kmeans clutering of 4 was applied.
Time-lapse imaging
P19 cells were co transfected with either pCAG-RFP, or pCAG-
Trnp1-IRES-RFP or pCAG-D1–16 Trnp1-IRES-RFP and the reporter
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plasmids GFP-Fbl1 or H2B-Venus, respectively. Cells were plated on
PDL-coated glass bottom microwell dishes (MatTek) with a glass
thickness of 0.16–0.19 mm. Imaging was performed on an inverse
confocal laser scanning microscope (FV1000, Olympus) using a 20×
air objective with NA = 0.7 (UPLAPO). During imaging, the cells
were incubated in a humidified stage-top incubator (Tokai Hit) at
37°C with 5% CO2. Confocal image stacks were acquired every
10 min with a z-step size of 1.5 lm for a total of eight optical
sections. The total imaging time was 16–72 h. For quantification,
the z-stacks were collapsed using the maximum projection in FIJI/
ImageJ.
To analyze the time a cell spent in different sub-phases of M-
phase, we identified the movie-frame when a cell first showed
condensation of the nuclear DNA by following H2B-Venus and then
measured the time until a clear separation of the two sister chro-
matids was detectable (condensation to separation) and subse-
quently measured the time until decondensation of the nuclear DNA
(separation to end of M-phase). Total length of M-phase was deter-
mined by the time from first condensation of nuclear DNA to the
end of DNA condensation.
In order to quantify the number and size of nucleoli around M-
phase, we employed multiple functions of FIJI/ImageJ. First, the cell
of interested was isolated by removing all fluorescence signals origi-
nating from other cells. To quantify the number and the area of
GFP-Fbl1 foci, we normalized the signal from each cell by employ-
ing the “Enhance Contrast” function aiming at 0.3% saturated pixels
in all movies. In order to get a better quantifiable binary picture, we
then used the “Threshold” function with default values followed by
“Watershed”. To then assess the number and size of GFP-Fbl1 foci,
we used the “Analyze Particle” function. The quantitative data
derived from the movies in FIJI/ImageJ were then imported to R
and centered around the first picture-frame when the separation of
the daughter cells was detectable.
Quantitative analysis of in utero electroporated cells
To quantify the distribution and percentage of Pax6, Tbr2, Ki67,
BrdU, and/or pHH3 electroporated cells, single optical sections
Olympus FV1000 confocal laser-scanning microscope) of each brain
slice were analyzed. Using FIJI/ImageJ, each stripe was divided into
five equally sized bins, adjusted to the radial thickness of the
embryonic cerebral cortex. Quantifications are given as
median  IQR. Different sections representing the full rostro-caudal
distribution of the electroporated area were used for quantifications
of each condition. For each condition (overexpression, knockdown
and corresponding controls), 4–8 embryos from 2 to 5 litters were
analyzed.
Number and volume measurements of nucleoli and condensed
chromatin spots in vivo were performed on Z-stack images acquired
with Olympus FV1000 confocal laser-scanning microscope using a
63×/1.35 N.A. water immersion objective. Whole nuclei were
recorded with a z-step size of 1 lm. Nucleoli, condensed chromatin
spots, and nuclei were counted and assigned to cells manually.
Values were saved and transferred to FIJI/ImageJ. The measure-
ments were performed for Ncl staining (present in DFC and GC) and
DAPI to determine nucleolar and condensed chromatin spots and
nuclei volumes, respectively. The resulting values were transferred
to an Excel sheet, and we used R software to calculate the average
area and the total number per cell. The results were displayed as
violin plots or dot plots, on which the data points represent individ-
ual cells. For each condition (overexpression and corresponding
controls), 10–15 cells were quantified 6 (GFP), 6 (for Trnp1), 3–4
(for D1–16Trnp1), 7 (shTrnp1), and 7 (shcontrol) different embryos
(from 3 to 5 different litters) for nucleoli and 6 (GFP and Trnp1) and
4 (D1–16Trnp1) different embryos (from 3 to 5 different litters) for
condensed chromatin.
Animals
Animal handling and experimental procedures were performed in
accordance with German and European Union guidelines and were
approved by the State of upper Bavaria. All efforts were made to
minimize suffering and number of animals. Two to three month
female C57BL/6J wild-type mice were maintained in specific
pathogen-free conditions in the animal facility, in 12:12-h light/
dark cycles and bred under standard housing conditions in the
animal facility of the Helmholtz Center Munich and the Biomedical
Center Munich. The day of the vaginal plug was considered
embryonic day (E) 0.
Plasmids
The pEGFP-C1-Fibrillarin (26673) and pCMV-L26-Flag (19972) were
purchased in Addgene. The murine Trnp1-expressing plasmid was
previously described (Stahl et al, 2013). Empty vectors were used as
controls. For sequence of primers used, see Table EV2. All plasmids
for expression were cloned from pENTR1a-Trnp1 gateway plasmid
described in Stahl et al (2013) into a Gateway (Invitrogen) form of
pCAG-GFP and pCAG-dsRed (kind gift of Paolo Malatesta). For that
purpose, we first used PCR to amplify the truncated forms from the
murine Trnp1-expressing plasmid using the different primers
containing specific restriction sites described in Table EV2. Cloning
was done by restriction digestion. Gateway LR-reaction system was
used to then sub-clone the different Trnp1 forms into the pCAG
destination vectors.
To produce the different recombinant 6HisxMBP-tagged Trnp1
proteins used in this study, we cloned all the sequences from the
pCAG plasmids into the plasmid pET-MBP1a (kind gift of Arie
Geerlof) using PCR amplification with specific primers containing
specific restriction sites. Automated sequencing was used to check
all constructs.
Cell lines
P19 cells (ATCC, VA, USA, CRL-1825) were maintained in DMEM
GlutaMAXTM (Life Technologies) supplemented with 10% FCS, 1×
NEAA (Life Technologies) and 1% penicillin/streptomycin (Life
Technologies).
Primary cortex cultures
E14 cortices were dissected removing the ganglionic eminence, the
olfactory bulb, the hippocampal anlage, and the meninges, and cells
were mechanically dissociated with a fire polish Pasteur pipette.
Cells were then seeded onto poly-D-lysine-coated glass coverslips in
DMEM-GlutaMAX with 10% FCS (Life Technologies).
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Plasmid transfection
Plasmid transfection was done with Lipofectamine 2000 (Life tech-
nologies) according to manufacturer’s instruction, and 24 h later,
cells were washed in PBS collected for protein extraction or fixed in
4% paraformaldehyde (PFA) in buffered in phosphate-buffered
saline (PBS) and processed for immunostaining.
M-phase analysis
P19 cells transfected for 16 h with plasmids expressing GFP (con-
trol) or Trnp1 with GFP were synchronization at end G2 by treat-
ment for 24 h with 9 mM of RO-3306 (Calbiochem). Cells were then
released for the different time points depicted in Fig 6F, fixed with
4% PFA, and stained for GFP and DAPI to visualize the chromatin.
Pictures for all conditions were done using epifluorescence micro-
scope (Zeiss, Axio ImagerM2) in a 20×/0.85 N.A water immersion
objective. Hundred cells were manually counted in each condition
to calculate the percentage of cells in each mitotic phase (inter-
phase, prophase, metaphase, anaphase, and telophase).
Super-resolution confocal microscopy (HyVolution)
Super-resolution confocal image was performed with an inverted Leica
SP8X WLL microscope, equipped with a pulsed WLL2 laser (470–
670 nm) and acusto-optical beam splitter. 0.8 lm thick image stacks at
a z-step size of 200 nm were acquired with a 100×/1.4 NA oil immer-
sion objective, scan speed was 100 Hz, and image pixel size was set to
39 nm. The pinhole was set to 0.6 AU (calculated for 633 nm). The
following fluorescence settings were used: B23, Alexa Fluor 488: (exci-
tation: 488 nm; emission: 496–535 nm), Ncl, Alexa Fluor 546: (561;
569–600), and Trnp1, Abberior STAR 635P: (633; 643–701). Recording
was done line sequentially to avoid bleed-through. A triple notch filter
(NF 488/561/633) was used to block reflected excitation light. All
signals were recorded with hybrid photodetectors (HyDs) in counting
mode. Stacks were deconvolved using Huygens Professional 17.10 p2.
Images shown are single planes of deconvolved stacks.
Transmission electron microscopy
Trnp1-IRES-GFP or GFP-transfected P19 cells were FACS sorted for
GFP at 1 day after transfection using a FACS Aria II (BD) in BD
FACS Flow TM medium. Debris and aggregated cells were gated out
by forward scatter (FSC-A) and side scatter (SSC-A); FSC-A vs. FSC-
W was used to discriminate doublets from single cells. Gating for
GFP+ cells was done using non-transfected cells. The FACS-sorted
cells were then washed in PBS (pH 7.2) and fixed in 1.6%
glutaraldehyde diluted in 0.1 M PBS (pH 7.2) at room temperature
(RT); after 1 h, they were washed in the same buffer. The samples
were acetylated according to Thiry et al (1985) before being embed-
ded in Epon. Ultrathin sections mounted on copper grids were
stained with uranyl acetate and lead citrate before examination with
a Jeol JEM 1400 transmission electron microscope (TEM) at 80 kV.
Immunostaining
Tissue sections (20 lm) or cells plated on poly-D-lysine-coated glass
coverslips were blocked with 2% BSA, 0.5% Triton-X (in PBS) for
1 h prior to staining. Primary antibodies (see Table EV1) were
applied in blocking solution overnight at 4°C. Fluorescent secondary
antibodies were applied in blocking solution for 1 h at room temper-
ature. DAPI (40,6-diamidin-2-phenylindol, Sigma) was used to visu-
alize nuclei. Sections were mounted in Aqua Polymount
(Polysciences). All secondary antibodies were purchased from Life
Technologies. Images were taken using an Olympus FV1000 confo-
cal laser-scanning microscope using 20×/0.85 N.A and 63×/
1.35 N.A. water immersion objective or epifluorescence microscope
(Zeiss, Axio ImagerM2) equipped with a 20×/0.8 N.A and 63×/
1.25 N.A. oil immersion objectives. Post-image processing with
regard to brightness and contrast was carried out where appropriate
to improve visualization, in a pairwise manner. See Table EV1 for
the list of primary and secondary antibodies. For staining of Trnp1,
a pretreatment with 2 N HCl for 30 min and subsequently neutral-
ized with sodium-tetraborate (Na2B4O7 0.1 M, pH: 8.5) for
2 × 15 min was done.
Analysis of protein co-localization by line scan
Protein co-localization after staining was determined using Olympus
FV1000 confocal laser-scanning microscope pictures and FIJI/
ImageJ software. Single z-stack images were taken at the foci. A
region of interest line (shown in yellow line) was drawn simultane-
ously in all channels analyzed so that it spanned the nucleus and
intersected the foci (Fig 4). Data of relative staining intensity vs.
distance were exported and processed using Microsoft Excel.
Analysis of protein turnover
P19 cells were transfected with the appropriate expression
construct. Twenty hours after transfection, cycloheximide (Sigma-
Aldrich) was added to the cultures to a final concentration of 20 lM
to inhibit new protein synthesis and protein lysates were collected
at different time points. To measure protein turnover after protea-
some inhibition, the cultures were treated in an identical manner
except that 10 lM MG132 was added to the cultures. Equal amounts
of protein in lysates from the different time points were then
analyzed by Western blot (WB). ImageJ was used to quantify
protein content in each sample and to calculate the rate of the dif-
ferent protein degradation by normalizing to the GFP protein (half-
life of 24 h) of the same sample.
Protein extract preparation
P19 cells were transfected with the appropriate expression plasmid
for 24 h. To obtain nuclear extracts, cells were first washed in ice-
cold 1× PBS, re-suspended in Tween20 lysis buffer (25 mM HEPES
pH 8, 20 mM NaCl, 2 mM EDTA, 1 mM PMSF, 0.5% Tween20, 1×
protease inhibitors, cOmplete, Roche), and incubated on ice for
30 min with gentle vortexing every 10 min. Nuclei were then
pelleted by centrifugation at 336 × g 10 min at 4°C, and the cyto-
plasmic fraction (supernatant) was then discarded or collected for
the nuclear cytoplasmic fractionation experiment. The nuclear frac-
tion was washed once with lysis buffer, re-suspended lysis buffer
containing 500 mM NaCl, incubated 30 min on ice, and sonicated
30 times for 1 sec ON/1 sec OFF at 30% input. Chromatin and cell
debris were pelleted at 13,500 × g for 15 min at 4°C, and the
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supernatant containing the nuclear proteins was recovered in a low-
protein-binding Eppendorf. For mass spectrometry experiments,
DNAseI (250 U; SIGMA) was added to the nuclear pellet and incu-
bated 1 h at 37°C. Finally, after a centrifugation at 16,000 × g for
15 min at 4°C, the supernatant was collected, mixed with the
nuclear proteins and the protein lysates (cytoplasmic and nuclear
depending on the experiment were snap-frozen to use in different
experiments).
For whole protein extract, cells were incubated 30 min with RIPA
buffer (Sigma) completed with 1× protease inhibitors, cOmplete
(Roche) prior to sonicate 30 times for 1 ON/1 sec OFF at 30%
input. Chromatin and cell debris were pelleted at 13,500 × g for
15 min at 4°C, and the supernatant containing the nuclear proteins
was recovered in a low-protein-binding Eppendorf and snap-frozen
for later experiments.
Protein co-immunoprecipitation (IP)
For co-immunoprecipitation, the nuclear protein extract was incu-
bated end-over-end with 10 lg of primary antibodies or FLAG
M2 Magnetic Beads (SIGMA) at 4°C for 2 h. When using antibod-
ies, 30 ll of a 1:1 mix of Dynabeads Protein G: Dynabeads
Protein A (Invitrogen) was used and incubated end-over-end at
4°C for 1 h. Beads were then separated with a magnet and
washed four times for 15 min at 4°C with washing buffer
((25 mM HEPES pH 7.6, 150 mM KCl, 12.5 mM MgCl2, 0.1 mM
EDTA, 10% glycerol) + 0.1% NP-40). For WB analysis, proteins
were eluted by cooking beads at 95°C with mixer at 600 rpm for
10 min in 2× Laemmli buffer and separated from the beads with
a magnet. For LC-MS/MS, beads were subsequently washed three
times with 50 mM NH4HCO3, incubated with 10 ng/ll trypsin in
1 M urea 50 mM NH4HCO3 for 30 min, washed with 50 mM
NH4HCO3 again, and digested ON in the presence of 1 mM DTT.
Digested peptides were alkylated and desalted prior to LC-MS
analysis.
Western blot
Gel electrophoresis was done with 10 or 15% SDS-polyacrilamide
gels depending of the molecular size of the respective protein and
then transferred to nitrocellulose membranes. For immunodetection,
membranes were first blocked with 5% nonfat dry milk in TBS/T
(Tris-buffered saline/0.1%Tween-20, pH 7.4) overnight, incubated
for 3 h with primary antibodies diluted in 1% nonfat dry milk in
TBS/T at RT and, after extensive washing with TBS/T, incubated
with horseradish peroxidase (HRP)-coupled secondary antibodies
diluted in 1% nonfat dry milk in TBS/T for 1 h. Signal was visual-
ized by ECL method on films (Amersham). For antibodies, see
Table EV1.
RNA extraction, cDNA synthesis, and qPCR
For qPCR analysis, P19 cells were transfected with the appropriate
expression constructs for 24 h and total RNA was isolated using the
Qiagen RNeasy kit. cDNA synthesis was performed using random
primers with the Maxima first strand synthesis kit (Thermo Scien-
tific). Real-time qPCR was conducted using SYBR green and Thermo
Fisher Quant Studio 6 machine. PCR primers are listed Table EV2.
For droplet experiments, RNA from E14 embryonic cortices was
isolated using the Qiagen RNeasy kit, quantified using Qubit RNA
HS Assay Kits (Life Technologies) according to the manufacturer,
and snap-frozen in small aliquots until use.
Recombinant protein expression and purification
All His6-MBP-tagged Trnp1 constructs and His6-MBP-tagged YFP
were transformed into Escherichia coli strain BL21 (DE3) and
cultured at 20°C in 2-l flasks containing 500 ml ZYM 5052 auto-
induction medium (Studier, 2005) and 100 lg/ml kanamycin. Cells
were harvested by centrifugation after reaching saturation, resus-
pended in 30 ml lysis buffer (50 mM Tris–HCl, 1 M NaCl, 20 mM
imidazole, 10 mM MgCl2, 10 mg/ml DNaseI, 1 mM AEBSF.HCl,
0.2% (v/v) NP-40, 1 mg/ml lysozyme, 0.01% (v/v) 1-thioglycerol,
pH 8.0), and lysed by sonication. The lysates were clarified by
centrifugation (48,000 × g) and filtration (0.2 lM). The super-
natants of His6-MBP-tagged Trnp1, D116, D1–140, and D95–223
were subjected to polyethylenimine (PEI) precipitation to remove
non-specifically bound nucleotides. 0.5% PEI (in 0.5 M Tris–HCl pH
8.0) was added to the supernatants and incubated for 10 min at 4°C
while stirring vigorously. The precipitate was removed by centrifu-
gation (48,000 × g). To remove the excess of PEI, ammonium
sulfate was added (95% saturation) to the supernatants and incu-
bated for 30 min at 4°C while stirring vigorously. Precipitated
proteins were collected by centrifugation (75,000 × g), and the
pellets were redissolved in 30 ml buffer A (50 mM Tris–HCl,
300 mM NaCl, 20 mM imidazole, 0.01% (v/v) 1-thioglycerol, pH
8.0), centrifuged to remove insoluble material, and applied to 5-ml
HiTrap Chelating HP column (GE Healthcare), equilibrated in buffer
A using an Äkta Purifier (GE Healthcare). The column was washed
with buffer A containing 50 mM imidazole, and bound proteins
were eluted with buffer B (50 mM Tris–HCl, 300 mM NaCl,
300 mM imidazole, 0.01% (v/v) 1-thioglycerol, pH 8.0). Fractions
containing protein were subsequently subjected to size exclusion
chromatography using a HiLoad 16/600 Superdex 200 column (GE
Healthcare) and equilibrated in buffer C (50 mM Tris–HCl, 300 mM
NaCl, and 0.01% (v/v) 1-thioglycerol, pH 8.0). Fractions containing
Trnp1 constructs were pooled and concentrated to 10–30 mg/ml,
flash-frozen in small aliquots, and stored at 80°C.
His6-MBP-tagged Trnp1CC and Trnp1mutCC and His6-MBP-tagged
YFP were purified as described above without the PEI and ammonium
sulfate precipitation steps. For the purification of His6-MBP-tagged
Trnp1CC and Trnp1mutCC, the IMAC buffers contained 1 M NaCl.
Static light scattering (SLS) experiments of MBP-tagged Trnp1CC
and Trnp1mutCC were performed at 30°C using a Viscotek TDA 305
Triple Array Detector (Malvern Instruments) downstream to an Äkta
Purifier (GE Healthcare) equipped with an analytical size exclusion
column (Superose 6 10/300 GL, GE Healthcare) at 4°C. 100 ll
samples were run at a flow rate of 0.5 ml/min in 50 mM Tris–HCl,
300 mM NaCl, 0.01% (v/v) 1-thioglycerol, pH 8.0, with a concentra-
tion of 1.91 mg/ml for CC and 1.19 mg/ml for mutCC, respectively.
His6-MBP-tagged Trnp1-CC was pre-purified on the superpose 6
column to remove highly aggregated protein, which would have
given a very strong scattering signal that would have interfered with
the analysis of the SLS experiments. The molecular masses of the
samples were calculated from the refractive index and right-angle
light-scattering signals using Omnisec (Malvern Instruments). The
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SLS detector was calibrated with a 4 mg/ml BSA solution with
66.4 kDa for the BSA monomer and a dn/dc value of 0.185 ml/g for
all protein samples.
In utero electroporation
Animals were operated as approved by the Government of Upper
Bavaria. E13 timed pregnant mice were anaesthetized by intraperi-
toneal (i.p.) injection of Fentanyl (0.05 mg/kg), Medetomidine
(0.5 mg/kg) and Midazolam (5 mg/kg). Plasmids were mixed with
0.1% Fast Green (Sigma) and injected at a concentration of 1 lg/ll.
In utero electroporations were performed as described earlier (Saito,
2006). Anesthesia was terminated by subcutaneous injection of
Buprenorphine (0.1 mg/kg), Flumazenil (0.5 mg/kg) and Atipame-
zole (2.5 mg/kg), and the mice were allowed to recover on a heating
pad and monitored according to the license. The embryonic brains
were collected 1 or 2 days after electroporation. To be able to
analyze the number of cells in S-phase, Bromodeoxyuridine-5-
bromo-20-deoxyuridine (BrdU) was injected I.P. one hour prior to
sacrifice the animals.
Tissue processing
Mouse E14 and E15 embryonic mouse brains were fixed for 4 and
5 h, respectively, in 4% PFA in PBS at 4°C. Brains were then
cryoprotected in 30% sucrose (in PBS) overnight, embedded in
tissue-tek, stored at 20°C, and then cryosectioned.
FACS analysis
For the in vivo experiment, E13 developing cortices were electropo-
rated with plasmid expressing the shRNA against Trnp1 together
with GFP or its control plasmid. Electroporated cerebral cortices
were collected 1 dpe (at E14) for FACS analysis. Three separate
biological replicates were performed with each replicate containing
10,000 GFP+ cells. For that, electroporated E14 cerebral cortices
were enzymatically dissociated with 0.5% Trypsin, at 37°C for
15 min. After dissociation, samples were washed in PBS by centrifu-
gation at 300 g for 10 min. In both experiments, cell suspension
was filtered through a 100-lm cell strainer and placed on ice for
analysis. FACS analysis was performed at a FACSAria III (BD Bios-
ciences) in FACSFlow sheath fluid (BD Biosciences), with a nozzle
diameter of 100 lm. Debris and aggregated cells were gated out by
forward and side scatter; single cells were selected by FSC-W/FSC-
A. Gating for GFP fluorescence was done using non-electroporated/
transfected cells. Flow rate during sorting was below 500 events/s.
RNA sequencing
RNA from FACS sorted in utero electroporated (GFP+) cells express-
ing the shRNA against Trnp1 together with GFP or its control was
isolated in Extraction Buffer (Arcturus), heated to 42°C, and stored
at 80°C until all samples were collected to be processed together.
Subsequently, total RNA was isolated using the PicoPure RNA Isola-
tion Kit as per the manufacturer’s instructions (Arcturus). cDNA
was synthesized from 300 pg of total RNA using SMART-Seq v4
Ultra Low Input RNA Kit for Sequencing (Clontech), according to
the manufacturer’s instructions. Prior to generating the final library
for Illumina sequencing, the Covaris AFA system was used to
perform the cDNA shearing, resulting in 200- to 500-bp-long cDNA
fragments. The quality and concentration of the sheared cDNA were
assessed on Agilent 2100 Bioanalyzer before proceeding to library
preparation using MicroPlex Library Preparation kit v2 (Diagenode).
Final libraries were evaluated and quantified using an Agilent 2100
Bioanalyzer, and the concentration was measured additionally with
Quant-iT PicoGreen dsDNA Assay Kit (ThermoFisher) before
sequencing. The uniquely barcoded libraries were multiplexed onto
one lane, and 150-bp paired-end deep sequencing was carried out on
HiSeq 4000 (Illumina) that generated ~ 30 million reads per sample.
The RNA-seq reads were mapped to the mouse genome refer-
ence (UCSC genome browser mm10) using mapsplice (Wang
et al, 2010) with default parameters. The percent splice in (PSI)
values were calculated for each alternative splicing events using
the MISO pipeline (Katz et al, 2010). To identify Trnp1-related
splicing events, we used the cutoffs: delta PSI > 0.1 or < 0.1
with Bayes factor > 5 and P value < 0.1(Student’s t-test) between
Trnp1 overexpression and GFP control overexpression for the
in vitro analysis and Trnp1 knockdown and its control in the
in vivo analysis. Gene expression levels were estimated using
RSEM (Li & Dewey, 2011). Differentially expressed genes were
identified using the R package “DESeq2”, and the cutoff is |
log2FoldChange| > 1 and P value < 0.05.
OPP-click translation assay
Translation rate was measured using the Protein Synthesis Assay
Kit (Cayman chemicals, 601100) in cells expressing RFP as control
or Trnp1 and RFP for 24 h. Following manufacturer’s instructions,
for OPP quantifications in immunostaining, all images within
compared groups were acquired with identical settings and analyzed
in FIJI/ImageJ software by quantification of pixel intensity. Quan-
tifications by FACS were performed in the FACSAria III (BD Bios-
ciences) and analyzed using FlowJo 10.6.2.
Statistical analyses
All manual counts were performed blind. Per experimental condi-
tion, quantifications in mouse brain sections were performed with
at least four brains from 2 to 4 different litters (see above). Quan-
tifications of primary cortical cells were done with brains from at
least three different litters per experimental condition. Quan-
tification of cells in live imaging experiments is derived from three
different experiments per experimental condition. Graphs were
done with GraphPad Prism 8, designer gravit (https://designer.gra
vit.io/), or R software. Data were statistically analyzed with
GraphPad Prism 8 or R software using Mann–Whitney test or
Kruskal–Wallis test with Dunn’s post hoc test, as indicated
throughout the manuscript.
Data availability
The mass spectrometry proteomics data have been deposited to the
ProteomeXchange Consortium via the PRIDE partner repository with
the dataset identifier PXD018350 (http://www.ebi.ac.uk/pride/arc
hive/projects/PXD018350).
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RNA-seq data of this study are available under accession number
PRJNA622767 which can be found in https://www.ncbi.nlm.
nih.gov/bioproject/PRJNA622767/.
Expanded View for this article is available online.
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